chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Beginning at midnight the night of my vaccine I began to shiver uncontrollably. I took 2  Tylenol and was able to sleep for a few hours. I awoke around 6 am with severe body aches, shivering, severe fatigue, upset stomach and extremely disoriented. This lasted for the next 30 hours. I continued to take Tylenol as needed for headaches and body aches. Eventually, the body aches subsided, but the head aches and sense of confusion and disorientation lasted for 2 more days. It has been 4 days since the vaccine and I still am experiencing what I would call a brain fog. It?s very scary and concerning to me.
Patient reported metallic taste in mouth feeling flushing in throat and chest. HR 113, 96% o2 RA was checked by paramedics and cleared refused treatment.
Neck stiff; Left armpit area swollen; Armpit area tender; Heart beat a couple of times felt veryrapid; Neck sore; Itchy throat; Wheezing; Aches, hit by a truck feeling; Sweats; Sore left arm; Headache; Nausea; This is a spontaneous report from contactable consumer, the patient. A 43-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: E86955 or EP6955) via an unspecified route of administration in the left arm on 28Mar2021 at 12:45 (at the age of 43-years-old) as a single dose, for COVID-19 immunisation. Medical history included asthma and body mass index (BMI). The patient did not have any allergies to medications, food, or other products. Concomitant medication included ibuprofen (MANUFACTURER UNKNOWN) on occasion for an unknown indication from an unknown date. The patient did not receive any other vaccine within four weeks of vaccination. It was unknown if the patient was diagnosed with COVID-19 prior to the vaccination. Since the vaccination, the patient had not been tested for COVID-19. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199), via an unspecified route of administration in the left arm on 07Mar2021 at 15:30 (at the age of 43-years-old) as single dose, for COVID-19 immunisation. On 28Mar2021 at 17:30 (also reported as night of second dose), the patient experienced sore left arm, itchy throat, wheezing (needed to use inhaler), headache, sweats, nausea, aches, hit by a truck feeling which lasted until end of day on 29Mar2021. On 30Mar2021, the patient felt better but her neck was stiff and sore and left armpit area swollen and tender and heart beat a couple of times felt very rapid. The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events of pain in arm, itchy throat, wheezing, headache, sweaty, nausea, pain, neck stiff, neck pain, local swelling, armpit pain and heart rate high was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
On 10/19/2021 I started feeling a scratchy throat, sniffles, runny nose, cough, pounding headache between my eyes. I think I had a fever because I had no energy. However, I did not take my temperature nor did urgent care. They did a covid test and it was positive. They told me to quarantine. I called my family doctor and we discussed doing antibody treatments  but I started feeling better the next day so I decided against it. Every symptom has gone away except for the cough. I am still dealing with that. I have taken cough medicine to help alleviate the cough. I am still currently in quarantine.
Shingrix administered subcutaneously; This case was reported by a pharmacist via call center representative and described the occurrence of intramuscular formulation administered by other route in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On 30th August 2022, the patient received Shingrix (subcutaneous). On 30th August 2022, unknown after receiving Shingrix, the patient experienced intramuscular formulation administered by other route. On an unknown date, the outcome of the intramuscular formulation administered by other route was unknown.    Additional Information: GSK Receipt Date: 30-AUG-2022 Reporter's Comments: The pharmacist called and reported that one of her colleagues had received Shingrix vaccination subcutaneously instead of intramuscularly. It was reported that as this happened on a different facility. The HCP did not provide any details from the situation reported. The health care professional (HCP) reported that he/she thought  it was today in regards of when was the patient vaccinated. No lot number and expiration date was provided. The vaccine administration facility was the same as primary reporter. The reporter consent to follow up. Additional Supportive Information: The patient received Shingrix subcutaneously, which led to intramuscular formulation administered by other route
It was reported that a pt who rec'd TD adult vaccination on 4/3/00. Reportedly on 4/4/00 the pt experienced extreme fatigue, body aches, fever 100F and chills. From correspondence rec'd on 5/1/00, it was reported no treatment was necessary, symptoms resolved on own. No localized reaction noted. Additional pt, vaccine and responsible physician information were also provided.
43 YO F C/O NUMB SENSATION IN HER FACE SOME UNUSUAL SENSATION IN HER TONGUE FOLLOWING COVID SHOT. DENIES OTHER C/O TO INCLUDE DIFFICULTYBREATHING, SWALLOWING, SPEAKING, DENIES SWELLING IN OR AROUND FACE/MOUTH, NAUSEA, OR OTHER C/O. PT INITIALLY WAS WILLING TO GO TO ER BUT HER SXSUBSIDED WHILE WAITING FOR AMBULANCE AND SHE DECIDED TO AMA AND FOLLOW UP ON HER OWN. FOUND ABOVE PT A/O X4, NO OBV DISTRESS, NO OBVIOUS ANGIOEDEMA, SPEAKS IN FULL SENTENCES, CLEAR LS BILAT ALL, SOME HIVE LIKE RASH ON ANTERIOR CHESTBELOW THE CLAVICLES, EXTREM - PWD, GOOD PMS X4, MOVES ALL WITH PURPOSE
arm is swollen; swelling at the injection site; very red and enlarged; fever 101; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (arm is swollen), VACCINATION SITE SWELLING (swelling at the injection site), VACCINATION SITE ERYTHEMA (very red and enlarged) and PYREXIA (fever 101) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced PERIPHERAL SWELLING (arm is swollen), VACCINATION SITE SWELLING (swelling at the injection site), VACCINATION SITE ERYTHEMA (very red and enlarged) and PYREXIA (fever 101). At the time of the report, PERIPHERAL SWELLING (arm is swollen), VACCINATION SITE SWELLING (swelling at the injection site), VACCINATION SITE ERYTHEMA (very red and enlarged) and PYREXIA (fever 101) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Jan-2021, Body temperature: 101° (High) Fever.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
NauseaVomiting fatigue, chills, red and sore arm Narrative:
Site: Pain at Injection Site-Mild, Systemic: Cardiac Disorder (diagnosed by MD)-Medium, Systemic: clot in artery-Mild, Systemic: Heart Attack-Mild, Additional Details: pt started symtpoms saturday night overnight after getting shot at 12pm.  was in hospital for 3 days getting heparin drip.  md says could be related to vaccine, but not sure.
Ischemia in left optic nerve causing permanent vision loss; Ischemia in left optic nerve causing permanent vision loss; This is a spontaneous report from a contactable (patient). A 43-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 2 via an unspecified route of administration, administered in Arm Right on 18Jan2021 10:00 (Batch/Lot Number: EL3248) as 2ND DOSE, SINGLE for covid-19 immunization. Medical history included intervertebral disc protrusion, Bulging disc C-Spine, endometriosis, and allergy to sulfa. The patient was previously vaccinated with first dose of bnt162b2, in left arm (Lot number: EK5730) on 28Dec2021 at 12.00pm for covid-19 immunization. Concomitant medications included ashwagandha; loratadine (CLARITIN); vitamins NOS (MV) taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received other medications within 2 weeks of vaccination. The patient was not diagnosed with COVID-19 and has not been tested for COVID-19 Since the vaccination. On 06Feb2021 08:00 the patient experienced ischemia in left optic nerve causing permanent vision loss. The patient received treatment for adverse event and events result in Doctor or other healthcare professional office/clinic visit. The outcome of events was not recovered.  No follow-up attempts are possible, information about lot/batch number cannot be obtained.; Sender's Comments: Based on known drug safety profile, there is reasonable possibility of causal association between the events blindness and ischemia and the suspect drug.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Slept from 2,pm until 8pm Slightly sore at injection sight Very thirsty
Evening of second dose extremely tired, headache,  next morning fever 100.3F with headace, general weakness, better with tylenol, second morning a sore and swollen lymph node under left arm (injection side)
Significant blood clotting in menstrual cycle; significant increased menstrual bleeding and wildly short menstrual cycles; starting with my first menstrual cycle after the 2nd dose of the covid vaccine, from June through now, my menstrual cycles and bleeding have been unlike anything I've experienced in my life, including significant blood clots that were large and shocking.
Severe arm pain with inability to move entire arm; headache, general weakness, excruciating pain; confined to bed for 3 days; loss of appetite; unable to walk with her walker; pain level 10; after 3 days her headache is gone and she is able to get out of bed; due to the C diff history we did not want to go to the hospital but daughter took care of patient 24/7 to monitor vitals; she was very sick; So sick, daughter was prepared to call an ambulance at any moment due to possible life threatening side effects.
PATIENT EXPERIENCED NAUSEA APX 5 MINUTES AFTER HIS VACCINATOIN. HE VOMITED. HE COMPLAINED OF COLD CHILLS AND A TINGLING IN HIS ARM.  WE OBSERVED HIM FOR APX 30 MINUTES AND HE WENT HOME WITHOUT MEDICAL INTERVENTION.
Hospitalization and death COVID-19 PNEUMONIA, ACUTE KIDNEY INJURY, HYPOXIC RESPIRATORY
Right leg shaking when awakened, occurred 3 times at home. Also had episode of right leg flexed and extended right arm, eyes staring straight ahead. Lasted a few seconds. Examined in the office - seemed OK. No fever, no URI symptoms, no vomiting or diarrhea. The next day seen in ER after right arm twitching, legs twitching and  head turned to left. This episode lasted about 15 seconds.
Information has been received from a physician concerning a female with "some health troubles" who on 30-NOV-2007 was vaccinated with Zostavax single dose of the series. The patient had a heart attack and died. The physician mention that she does not think it was due to Zostavax as the patient had "some health trouble before." Additional information is not expected.
10min p/vax cool, clammy, nausea, side pain, light headed, h/a, BP 100/70;sx completely gone p/10 min of monitor;
Just below the injection site I have a lump,; injection site was sore/that is red and sore; that is red and sore; This case was reported by a consumer via interactive digital media and described the occurrence of nodule in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On 12th September 2022, the patient received the 1st dose of Shingles vaccine. In September 2022, less than a week after receiving Shingles vaccine, the patient experienced nodule, pain and erythema. On an unknown date, the outcome of the nodule, pain and erythema were unknown.   It was unknown if the reporter considered the nodule, pain and erythema to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 14-SEP-2022 Reporter's comment: This case was reported by the patient via interactive digital media.  The reporter stated that he/she had received first shingle vaccine on 12th September 2022. The Injection site was sore. Just below the injection site he/she had a lump, that was red and sore. The reporter had asked if it was normal or not.  Follow-up would not possible, as no contact, details were available.
Tired, sore arm and dizzy. In addion, my left foot has been numb a few after after taking the first dose. I went to get my second doze and I told the person at pharmacy that I was having this problem, they did not want to give me the 2nd dose, though I persisted because I need it to return to work. I told them that it might get bette after second dose. They told me that I should see a doctor. I was hoping it would go away. It has gotten worse, at first it was hust the top of the foot and three toes, but now its the entire foot and I am in pain as well. I have scheduled an appointment with my doctor on November 8, 2021, I was informed it if gets worse to go to the ER.
First night- body ache, fever 2nd day- lymph node swollen on my left armpit and it?s painful, tiredness and weak.
Cellulitis like reaction; This case was reported by a consumer via interactive digital media and described the occurrence of cellulitis in a patient who received Men B NVS (Meningococcal B vaccine) for prophylaxis.   On an unknown date, the patient received Meningococcal B vaccine. On an unknown date, 1 week after receiving Meningococcal B vaccine, the patient experienced cellulitis (serious criteria GSK medically significant). On an unknown date, the outcome of the cellulitis was unknown.   The reporter considered the cellulitis to be related to Meningococcal B vaccine.  Additional details were provided as follows: The age at vaccination was not reported. After receiving Meningococcal B vaccine, the patient experienced cellulitis like reaction.
not gotten their periods; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of MENSTRUAL DISORDER (not gotten their periods) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MENSTRUAL DISORDER (not gotten their periods). At the time of the report, MENSTRUAL DISORDER (not gotten their periods) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Pain in the injection site/Pain is severe; Patient received 3rd dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Pain in the injection site/Pain is severe) and EXTRA DOSE ADMINISTERED (Patient received 3rd dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Pain in the injection site/Pain is severe) and EXTRA DOSE ADMINISTERED (Patient received 3rd dose). At the time of the report, VACCINATION SITE PAIN (Pain in the injection site/Pain is severe) outcome was unknown and EXTRA DOSE ADMINISTERED (Patient received 3rd dose) had resolved.            No concomitant medications were provided. No treatment medications were reported.    Reporter did not allow further contact
Patient is 16 years of age.  Moderna was given inadvertently.  Counseled patient and mom on vaccine being given incorrectly.
Headache, Achy all over, chills Treated with Tylenol with relief for a couple hours and symptoms returned. Next day began fever 101.1 and nausea with headache arm soreness and achy all over. Treated with Tylenol, fever would go down but then spike back up. Emesis x2.
This case was reported by a pharmacist via call center representative and described the occurrence of adverse reaction in a adult patient who received SHINGRIX. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced adverse reaction. On an unknown date, the outcome of the adverse reaction was unknown. It was unknown if the reporter considered the adverse reaction to be related to SHINGRIX. Additional information was received as follows: The age at vaccination was not reported. The pharmacist refused to provide any information as she was not the person who spoke to the patient. The healthcare professional refused to provide the actual adverse event.
Information has been received from a physician concerning a patient who "several months ago" was vaccinated with a dose of MMR II (lot# not provided). Concomitant therapy included Poliovirus vaccine (manufacturer unknown). Subsequently the patient experienced a febrile seizure. Patient sought unspecified medical attention. Upon internal review, febrile seizure was determined to be an other important medical event. At the time of the report the patient had recovered. Additional information has been requested.
1 ml dose of VAQTA was administered to one pediatric patient; No adverse effects reported; Information has been received from a medical assistant and refers to a  pediatric patient of unknown age and gender.      The patient's concurrent conditions, medical history and concomitant therapies were not reported.  On an unknown date, the patient was vaccinated intramuscularly with 1 ml adult dose of hepatitis a vaccine, inactivated (VAQTA) lot # R002487, expiration date 21-APR-2019, for prophylaxis. No adverse effects were reported.
She gained some weight and she thinks she was told she was 84 or 86 kg at the clinic. She weighs about 175 pounds; An EKG was done and she was told she had a prolonged qt interval; Her blood pressure went really high to 177/110; This is a spontaneous report from a contactable consumer. This consumer [patient] reported that the 48-year-old female patient received bnt162b2 (BNT162B2, Batch/lot number: EK5730), via intramuscular injection in left upper arm on 19Dec2020 07:30 am at single dose for covid-19 immunisation (Preventative). Medical history and concomitant medications were none. She got the Pfizer Biontech covid vaccine on the 19Dec. She was sent over to ER from the (clinic name) since her blood pressure went really high to 177/110 on 19Dec2020. Her blood pressure stayed around 170/100 and then she would rest for 10-15 minutes, the ER kept her there till her blood pressure went to about 144 or 150 and then she went home. She confirmed she was not admitted. She was told to go back to the ER if her blood pressure went up. An EKG was done and she was told she had a prolonged qt interval on 19Dec2020. She has not had an EKG since and was told to follow up with her doctor. Treatment: declines any, they just monitored her. When querying weight, states she knows she gained some weight and she thinks she was told she was 84 or 86 kg at the clinic. She weighs about 175 pounds. Reports she had some blood work done at the ER and it came back normal. She does not have any health conditions. She has an allergy to Cipro and fexofenadine. Vaccination Facility Type was Hospital. No Vaccine Administered at Facility. History of all previous immunization with the Pfizer vaccine considered as suspect (or patient age at first and subsequent immunizations if dates of birth or immunizations are not available was none. Additional Vaccines Administered on Same Date of the Pfizer Suspect was none. AE(s) required a visit to Emergency Room. No Physician Office. Prior Vaccinations (within 4 weeks) was none. AE(s) following prior vaccinations was None. The outcome of the events was unknown.
approx 15min p/vax pt flushed w/gen urticaria, screaming & restless;skin hot to touch;DPH;
Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Mild, Systemic: Dizziness / Lightheadness-Mild, Additional Details: throat felt itchy/swollen; benadryl resolved feeling
My arm has been sore for about 2 months now. Not a severe pain like 1-2 days after the vaccine but a constant soreness.
BLURRY AND DIVIDED VISION; TROUBLE WITH MOBILITY; This spontaneous report received from a patient concerned a 78 year old male. The patient's height, and weight were not reported. The patient's past medical history included stroke. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the subject experienced blurry and divided vision, and trouble with mobility. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from blurry and divided vision, and trouble with mobility. This report was non-serious.
I suffered from extreme joint pain in my feet & ankles.  At first I suspected it was just immune response related but it escalated into arthritic inflammation, mostly in my feet & ankles.  It caused swelling in those areas as well as other parts of my feet closer to my toes, my knees, my hands in random locations & my wrists.  I also developed a peculiar rash on my forearms, a tiny bit on the back of my neck, a tiny bit on my hands & on one knee.  I also was under continuous fever, only spiking to 104? a few times over the 4-5 weeks of suffering.  During much of the time I had a fever I also was under tachycardia, but never outside the range of 110bpm unless it was one of the few instances where my fever spiked much higher into the 103? - 104? range.
Redness, warm to touch, swelling at both injection sites (Left & Right thigh) per mother.